Medline Inc. is 13.8x more valuable than HAEMONETICS CORP by market capitalization ($49.12 B vs $3.55 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | HAE | MDLN |
|---|---|---|
| Market cap | $3.55 B | $49.12 B |
| US-listed rank | #1690 | #330 |
| Revenue (latest FY) | $1.33B | $28.43B |
| Net income (latest FY) | $97.31M | $1.16T |
| Net margin | 7.3% | 4069.4% |
| P/E (trailing FY) | 36.5 | 0.0 |
| SEC filings | 1,875 | 103 |
Medline Inc. is 13.8x more valuable than HAEMONETICS CORP by market capitalization ($49.12 B vs $3.55 B).
In their latest fiscal years, HAEMONETICS CORP reported $1.33B in revenue while Medline Inc. reported $28.43B.
Full pages: HAEMONETICS CORP and Medline Inc., or browse the full rankings.